NICE has once again rejected new drugs for early Alzheimer’s disease because the costs are too great to justify the small ...

While many are aware of memory problems as a sign of dementia, there's another early symptom of the disease to be mindful of.

An advocate for New Brunswick patients suffering from unusual neurological symptoms is calling for the retraction of a recent scientific report that found no evidence of a mystery brain disease in the ...

Frequent napping may be an early sign of Alzheimer’s. New research links disrupted sleep to damage in brain areas that control alertness, potentially speeding up cognitive decline.

Explore key strategies for managing dementia confusion and Alzheimer’s. Learn about recognizing signs, using the Confusion Assessment Method, and adapting daily routines for better care of affected in ...

Medical professionals and family members pleaded with UC San Diego Health Tuesday to scrap plans to close its 14-bed ...

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s. They represent a huge step forward in research because they target a known cause of the disease, ...

The National Institute for Health and Care Excellence is standing by its earlier decision to turn down donanemab and ...

Two drugs to treat Alzheimer’s disease have been rejected for use on the NHS because their benefits are “too small” to justify their cost, the health spending watchdog has said.

Scientists and doctors remain divided on the targeted antibody drugs that slow down the early stages of Alzheimer’s ...

Close to eight million adults in the US have symptoms of dementia and 500,000 people are diagnosed every year.